Gylling Helena, Rajaratnam Radhakrishnan A, Vartiainen Erkki, Puska Pekka, Miettinen Tatu A
Department of Clinical Nutrition, University of Kuopio, and Kuopio University Hospital, Kuopio, Finland.
Menopause. 2006 Mar-Apr;13(2):286-93. doi: 10.1097/01.gme.0000174095.49029.56.
Especially in women, serum cholesterol lowering with cholesterol malabsorption using plant sterol ester margarine has revealed controversial results. Accordingly, in this retrospective study, we evaluated whether plant stanol (3 g/d) ester margarine consumption for 6 and 12 weeks lowers serum cholesterol levels in mildly hypercholesterolemic women without (n = 38) and with (n = 22) coronary heart disease.
The study population was selected from two of our earlier studies correspondingly matched for age, body mass index, and serum cholesterol and triglyceride levels. In addition, the long-term effect (12 months) of plant stanol ester with a dose reduction after 6 months (from 3-2 g stanol/d) was studied in the noncoronary group.
At baseline, the coronary and noncoronary groups had similar serum lathosterol (synthesis marker) and campesterol and sitosterol (absorption markers) ratios to cholesterol, but high-density lipoprotein cholesterol was lower and serum squalene and desmosterol ratios to cholesterol were significantly higher in the coronary versus noncoronary groups. Short-term plant stanol ester consumption reduced serum cholesterol by 8.7% (P < 0.001) in the coronary group from the control margarine period, and in the noncoronary group by 11% from the control group (P < 0.001). The cholesterol-lowering effect sustained unchanged in the noncoronary subjects during one year consumption despite reduction of the plant stanol intake from 3 g/d to 2 g/d.
Plant stanol ester margarine consumption effectively reduced serum cholesterol in postmenopausal women with and without coronary artery disease in short-term and for at least 1 year in the noncoronary group, suggesting that stanol ester margarine might be used in the long-term for cholesterol lowering in women.
尤其是在女性中,使用植物甾醇酯人造黄油降低血清胆固醇并伴有胆固醇吸收不良的情况,其结果存在争议。因此,在这项回顾性研究中,我们评估了轻度高胆固醇血症且无冠心病(n = 38)和有冠心病(n = 22)的女性,食用植物甾烷醇(3克/天)酯人造黄油6周和12周后血清胆固醇水平是否降低。
研究人群选自我们之前的两项研究,在年龄、体重指数、血清胆固醇和甘油三酯水平方面进行了相应匹配。此外,在非冠心病组中研究了植物甾烷醇酯的长期效果(12个月),6个月后剂量减少(从3克甾烷醇/天降至2克/天)。
在基线时,冠心病组和非冠心病组的血清羊毛甾醇(合成标志物)、菜油甾醇和豆甾醇(吸收标志物)与胆固醇的比值相似,但冠心病组的高密度脂蛋白胆固醇较低,血清角鲨烯和脱氢胆固醇与胆固醇的比值显著高于非冠心病组。短期食用植物甾烷醇酯后,冠心病组血清胆固醇较对照人造黄油期降低了8.7%(P < 0.001),非冠心病组较对照组降低了11%(P < 0.001)。在非冠心病受试者中,尽管植物甾醇摄入量从3克/天降至2克/天,但在一年的食用期间,降胆固醇效果保持不变。
食用植物甾烷醇酯人造黄油在短期内有效降低了有和没有冠状动脉疾病的绝经后女性的血清胆固醇,在非冠心病组中至少持续了1年,这表明甾烷醇酯人造黄油可能长期用于女性降低胆固醇。